-
Will the research and development of new drugs be restricted after price control?
Time of Update: 2021-09-18
Reduce 60 new drugs on the market within 30 years The CBO report explains that if Congress approves legislation that allows medical insurance to limit the reimbursement of certain major drugs, why companies investing in new drug development may abandon long-term and expensive drug research .
-
Guidelines for Joint Research Projects between the National Science Foundation and the National Science Foundation of the United States
Time of Update: 2021-09-18
cn/egrantweb/), and write the "National Natural Science Foundation of China International (Regional) Cooperation and Exchange Project Application" in accordance with the outline and related requirements.
-
BTK inhibitor fails Sanofi closes San Francisco laboratory and lays off 38 employees!
Time of Update: 2021-09-18
Just days after the company's key BTK inhibitor failed in a clinical trial, Sanofi now revealed that it will close Principia's laboratory in San Francisco and lay off more than 30 employees .
-
The global cumulative number of confirmed cases of new crown reached 222,406,582
Time of Update: 2021-09-18
WHO: The global cumulative number of confirmed cases of new crown reached 222,406,582 WHO: The global cumulative number of confirmed cases of new crown reached 222,406,582 WHO: The
-
The growth rate of the four varieties exceeds 100%!
Time of Update: 2021-09-18
According to MENET data, in 2020, the amount of anti-tumor small molecule targeted drugs in public hospitals in key provinces and cities in China will be nearly 15 billion yuan, an increase of 11.
-
Africa's third wave of epidemics is waning but still faces multiple challenges
Time of Update: 2021-09-18
Comprehensive news: Africa's third wave of epidemic is weakening but still faces multiple challenges Comprehensive news: Africa’s third wave of epidemics is weakening but still face
-
Research shows that the blood pressure of the elderly is better to be controlled within 130 mm Hg
Time of Update: 2021-09-18
Expert: The latest research shows that it is better to control the blood pressure of the elderly within 130 mmHg Expert: The latest research shows that it is better to control the b
-
Is an allergy after vaccination an abnormal reaction?
Time of Update: 2021-09-18
Expert Q & A CCTV News, Beijing, September 10 (Reporter Qin Liling) According to CCTV news, recently, in response to public concerns about whether people with a history of allergies can be vaccinated against the new crown virus, Wang Huaqing, chief expert of the China Centers for Disease Control and Prevention's immunization program, was in the State Council for joint prevention and control.
-
Experts suggest that men also need to do HPV infection prevention work
Time of Update: 2021-09-18
Professor Wang Qianqiu, director of the Clinical Prevention and Treatment Office of the STD Control Center of the Chinese Center for Disease Control and Prevention, researcher and chief physician of the Dermatology Hospital (Institute) of the Chinese Academy of Medical Sciences , said that after becoming a subclinical infection, the patient’s skin and mucosal manifestations are normal, but if If you do an HPV nucleic acid test, you will be positive .
-
Peru study: vaccinated people are less susceptible to new crowns and have lower mortality
Time of Update: 2021-09-18
Peru study: vaccinated people are less susceptible to COVID-19 and have lower mortality China News Service, September 15th.
-
Over 1 billion people in my country have completed the full vaccination of the new coronavirus vaccine
Time of Update: 2021-09-18
State Council According to Mi Feng, a spokesperson for the National Health Commission, as of September 15, a total of 21,614,428 doses of new coronavirus vaccines had been reported nationwide, and the number of people who had completed the entire vaccination was 101.
-
U.S. experts and other publications claim that ordinary people do not need to receive the third dose of new crown vaccine
Time of Update: 2021-09-18
S. Food and Drug Administration (FDA) and a team of experts including the World Health Organization (WHO) published an article in the British medical journal The Lancet on the 13th Said that there is no data or evidence to show that ordinary people need to receive the third dose of the new crown vaccine widely .
-
The diagnosis is only 38 days after entering China. Should the quarantine period be lengthened?
Time of Update: 2021-09-18
In February last year, Cai Weiping, an expert in the treatment team of the Guangdong New Coronary Pneumonia Prevention and Control Headquarters and director of the Infectious Diseases Center of the Eighth People's Hospital of Guangzhou City, once introduced that the "incubation period" refers to the time from a patient's infection with the virus to the appearance of the first symptoms, rather than a nucleic acid test.
-
CStone's multispecific antibody CS2006/NM21-1480 China clinical trial application approved
Time of Update: 2021-09-18
According to its molecular design, CS2006/NM21-1480 can only conditionally induce the immune costimulatory receptor 4-1BB and activate anti-cancer T cells when combined with the immune checkpoint ligand PD-L1 on the surface of tumor cells.
-
The sales myth of new crown drugs
Time of Update: 2021-09-13
The net profit of the new crown vaccine reached 34-40 billion yuan; Fosun Pharma's revenue in the first half of the year was 500 million yuanWith such attractive market returns, the development of new crown therapeutic drugs on a global scale is naturally in full swing, including vaccines, neutralizing antibodies, and oral drug projects of many Chinese companies are also accelerating to the goal of phase III and listing .
-
State Food and Drug Administration: Olympus, Braun Medical and other four companies actively recalled medical devices
Time of Update: 2021-09-13
voluntarily recalled the electronic bronchoscope (registration number: National Food and Drug Administration (Jin) 2006 No.
Braun Surgical SA voluntarily recalls Monosyn Synthetic absorbable surgical sutureBraun Medical Spain Joint Stock Company B.
Braun Surgical SA voluntarily recalls Monosyn Synthetic absorbable surgical sutureBraun Medical (Shanghai) International Trade Co.
-
Soaring 223.21%!
Time of Update: 2021-09-13
As an established pharmaceutical company, Fosun Pharma's generic drugs are also facing the impact of centralized procurement, and innovative products have become a strong "blood transfusion" support .
In the first half of the year, the sales revenue of Fosun Pharma's anti-tumor and immunomodulation core products increased by 256.
-
AstraZeneca fulvestrant and CDK4/6 inhibitor combination therapy approved in China
Time of Update: 2021-09-13
Source: Guanlan PharmaceuticalOn the evening of August 27th, AstraZeneca China announced that the National Medical Products Administration (NMPA) of China has officially approved the combined treatment of fulvestrant injection (fulvestrant) and the CDK4/6 inhibitor abexili, which is suitable for Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer is used for patients who have experienced disease progression after receiving endocrine therapy .
-
The first major overhaul in 22 years!
Time of Update: 2021-09-13
Changde City Health Health in the Second People's Hospital of Changde City Committee law enforcement inspection found 2018 - September January 2019, the hospital physician community level in yuan issued in Zhongshan Chi Pharmaceutical Group production of traditional Chinese medicine prescription Broken Pieces At that time, he received two cash rebates from Tang Huian, the manager of the basic medicine division of Hunan Mingjia Pharmaceutical Co.
-
Janssen's potential "first-in-class" bispecific antibody is clinically approved in China
Time of Update: 2021-09-13
Text|Pharmaceutical Mission HillsThe Center for Drug Evaluation (CDE) of the National Medical Products Administration of China revealed that the Class 1 new drug, talquetamab injection, declared by Johnson & Johnson's Janssen company, has obtained the implied license for clinical trials and is intended to be developed for multiple bone marrow.
